In female BALB/C mice with asthma, the PCI-34051 and givinostat groups had significantly lower Penh values than the asthma group. The asthma group also had significantly higher total BALF cell numbers than the DXM, TSA, PCI-34051, and givinostat groups. In male mice, daily intraperitoneal PCI-34051 treatment reduced BAPN-induced AD incidence compared with BAPN + DMSO, with reported incidences of 70.59% versus 40%. [2,3]
Enhanced Pause in a Mouse Asthma Model
Animal study · mouse model of asthma; female BALB/C mice; n = 8 for each group [2]
Female BALB/C mice in an asthma model received PCI-34051 at 0.5 mg/kg by intraperitoneal injection 30 min before excitation. The PCI-34051 and givinostat groups had significantly lower enhanced pause (Penh) values than the asthma group.
Conditions shared by the study groups
- Route
- intraperitoneal injection
- Treatment course
- 30 min before excitation
- PCI-34051 0.5 mg/kg
- Model: mouse model of asthma; female BALB/C mice; n = 8 for each group
- Reported limits: Not stated in the sentences used: vehicle.
Methods and source locations
Compound reported in the paper: PCI-34051
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Materials and methods > Mice and treatment (S1, S2, S8, S9, S10); Materials and methods > Detection of airway responsiveness (S14); Results (S52, S55)
Enhanced pause (Penh): Enhanced pause (Penh); comparator: asthma group — Materials and methods > Detection of airway responsiveness (S14); Results (S52)
PCI-34051 0.5 mg/kg · Materials and methods > Mice and treatment (S10); Results (S52)
BAPN-induced aortic dissection incidence in mice
Animal study · 3-week-old C57BL/6J mice [3]
PCI-34051 was injected intraperitoneally at a dose of 30 mg/kg every day. After four weeks of treatment, compared to DMSO, treatment with PCI-34051 resulted in a reduction in the incidence (70.59% vs. 40%) of BAPN-induced AD in male mice.
Conditions shared by the study groups
- Route
- intraperitoneally
- Treatment course
- every day
- Vehicle
- DMSO
- PCI-34051 30 mg/kg
- Model: 3-week-old C57BL/6J mice
Methods and source locations
Compound reported in the paper: PCI-34051
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Results > PCI-34051 attenuated BAPN-induced AD through inhibiting ferroptosis in mice (S58, S59); Methods > Animal experiments (S76); Figure 7. legend (S252)
The incidence of AD or aortic dilation: The incidence of AD or aortic dilation; comparator: BAPN + DMSO — Results > PCI-34051 attenuated BAPN-induced AD through inhibiting ferroptosis in mice (S59); Figure 7. legend (S252)
PCI-34051 30 mg/kg · Results > PCI-34051 attenuated BAPN-induced AD through inhibiting ferroptosis in mice (S58, S59)
BALF Total Cell Numbers in a Mouse Asthma Model
Animal study · mouse model of asthma; female BALB/C mice; n = 6 for each group [2]
Female BALB/C mice in an asthma model received PCI-34051 at 0.5 mg/kg by intraperitoneal injection 30 min before excitation. The asthma group had significantly higher total cell numbers in BALF than the DXM, TSA, PCI-34051, and givinostat groups.
Conditions shared by the study groups
- Route
- intraperitoneal injection
- Treatment course
- 30 min before excitation
- PCI-34051 0.5 mg/kg
- Model: mouse model of asthma; female BALB/C mice; n = 6 for each group
- Reported limits: Not stated in the sentences used: vehicle.
Methods and source locations
Compound reported in the paper: PCI-34051
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Materials and methods > Mice and treatment (S1, S2, S8, S9, S10); Materials and methods > Quantification of various types of cells in BALF (S25); Results (S74, S76)
total cells and cells of different types in BALF: total cells and cells of different types in BALF; comparator: asthma group — Materials and methods > Quantification of various types of cells in BALF (S25); Results (S74)
PCI-34051 0.5 mg/kg · Materials and methods > Mice and treatment (S10); Results (S74)